Novo Nordisk Investigational Site

Arlington, Virginia 22206

0 studies enrolling now · 11 studies all time

What they study most

Diabetes, Diabetes Mellitus, Type 2, Inflammation, Metabolism and Nutrition Disorder, Obesity, Overweight, Rheumatoid Arthritis

Studies at this site

• Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity — Completed
• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity — Completed
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity — Completed
• Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program — Completed
• Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus — Completed
• Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting — Completed
• Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes — Completed
• Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes — Stopped early
• A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics — Stopped early
• Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes — Stopped early
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes — Completed